Recce Pharmaceuticals Ltd (ASX:RCE)
Australia
· Delayed Price · Currency is AUD 0.430
-0.030 (-6.52%)
At close: Mar 9, 2026
Recce Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -30.25 | -21.43 | -17.66 | -13.08 | -10.99 | -13.51 | Upgrade
|
| Depreciation & Amortization | 0.34 | 0.36 | 0.37 | 0.22 | 0.19 | 0.3 | Upgrade
|
| Stock-Based Compensation | 1.34 | 1.34 | 0.02 | 0.33 | 0.26 | 5.22 | Upgrade
|
| Other Operating Activities | 6.28 | - | - | - | - | - | Upgrade
|
| Change in Accounts Receivable | 0.28 | 0.28 | 0.06 | 0.09 | 0.06 | -0.2 | Upgrade
|
| Change in Accounts Payable | -0.53 | -0.53 | 3.81 | 0.77 | 0.11 | 0.28 | Upgrade
|
| Change in Other Net Operating Assets | -0.46 | -0.46 | 0.39 | -1.01 | 1.36 | 0.07 | Upgrade
|
| Operating Cash Flow | -23.01 | -20.44 | -13.01 | -12.69 | -9.01 | -7.86 | Upgrade
|
| Capital Expenditures | -0.04 | -0.03 | -0.14 | -0.04 | -0.04 | -0.08 | Upgrade
|
| Investment in Securities | -0.24 | -0.24 | - | - | - | - | Upgrade
|
| Other Investing Activities | 0.39 | -0.18 | -0.16 | - | - | - | Upgrade
|
| Investing Cash Flow | 0.12 | -0.44 | -0.3 | -0.04 | -0.04 | -0.08 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 2.88 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 12.22 | 10.09 | - | - | - | Upgrade
|
| Total Debt Issued | 12.22 | 12.22 | 10.09 | 2.88 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -11.92 | -4.51 | -0.17 | -0.14 | -0.17 | Upgrade
|
| Total Debt Repaid | -5.55 | -11.92 | -4.51 | -0.17 | -0.14 | -0.17 | Upgrade
|
| Net Debt Issued (Repaid) | 6.67 | 0.31 | 5.58 | 2.71 | -0.14 | -0.17 | Upgrade
|
| Issuance of Common Stock | 28.35 | 28.35 | 11.15 | 0.1 | 0.29 | 28.06 | Upgrade
|
| Other Financing Activities | -13.71 | -1.74 | -0.56 | -0.1 | -0.39 | -1.76 | Upgrade
|
| Financing Cash Flow | 21.31 | 26.92 | 16.17 | 2.71 | -0.24 | 26.12 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 | - | Upgrade
|
| Net Cash Flow | -1.58 | 6.03 | 2.85 | -10.02 | -9.29 | 18.19 | Upgrade
|
| Free Cash Flow | -23.04 | -20.47 | -13.15 | -12.73 | -9.05 | -7.93 | Upgrade
|
| Free Cash Flow Margin | -2364.45% | -272.59% | -261.53% | -291.53% | -293.38% | -484.42% | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.09 | -0.07 | -0.07 | -0.05 | -0.05 | Upgrade
|
| Cash Income Tax Paid | - | -6.74 | -4.91 | -4.31 | -3.08 | -1.57 | Upgrade
|
| Levered Free Cash Flow | -9.45 | -12.6 | -7.73 | -8.16 | -4.52 | -3.1 | Upgrade
|
| Unlevered Free Cash Flow | -8.6 | -11.84 | -7.21 | -8.05 | -4.51 | -3.09 | Upgrade
|
| Change in Working Capital | -0.71 | -0.71 | 4.27 | -0.15 | 1.53 | 0.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.